Quotient (QTNT) Announces Proposed $60M Common Share Offering

Go back to Quotient (QTNT) Announces Proposed $60M Common Share Offering

Quotient (QTNT) Prices 17.647M Upsized Common Offering at $4.25/Sh

September 11, 2020 5:53 AM EDT

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the upsize and pricing of a $75 million underwritten public offering. The Company is offering 17,647,059 ordinary shares at a price to the public of $4.25 per share. The offering was upsized from the previously announced... More

Quotient (QTNT) and Ortho Clinical Diagnostics Settle Arbitration and Sign Binding LOI Covering Patient Transfusion Diagnostics

September 8, 2020 6:25 AM EDT

Quotient Limited (NASDAQ: QTNT), headquartered in Eysins, Switzerland, today announced that the Company and Ortho Clinical Diagnostics (Ortho) have signed a binding letter of intent that confirms the termination of their former distribution agreement and related contracts and resolves all their disputes over the former distribution agreement. In addition, this ends the pending arbitration between the two companies and establishes a new distributor relationship focused solely on... More